Training with the product IQoro (1.5 minutes per day) treats orofacial disorders such as dysphagia, hiatus hernia, GERD symptoms and snoring/apnoea. Study examples: 71% of patients with brain-damage dysphagia get sustainable normalized swallowing capacity (97% have a significant improvement); 100% of hiatus hernia patients become significantly improved (between 53-74% are totally symptom free, depending on the symptom).MYoroface is already growing fast and profitably, mainly in the B2C channel, and has just commenced its international expansion.

Neuromodulation medical device company focusing on migraine and chronic rhinitis treatments.

Bisphosphonate screw nanocoating technology to strengthen bone locally for better screw-bone implant connection, primarily within dental applications. Project terminated after a negative study.

Investments, corporate finance and SPAC project in FinTech and Nordic financial services.

Drug detection by using exhaled breath in the sports as well as the workplace markets.

Swedish full range food retailer with focus on organic products and small-scale producers.

Responsible for investment in LGT (furniture logistics).

Transactions: Stenqvist, DSV Miljö, Alimak Hek.

Sourcing SaaS software tools.

Mid-cap private equity investments throughout Europe.

M&A and Corporate Finance.